Previous 10 |
CORAL GABLES, FL / ACCESSWIRE / January 24, 2019 / The pharma stock market was built on the framework and understanding that, as medical experts discover new diseases, companies in the sector are responsible for creating innovative treatment options to combat these ailments. It is for this...
The FDA has approved Teligent's (NASDAQ: TLGT ) abbreviated new drug application (ANDA) of Clobetasol Propionate Ointment USP, 0.05%. More news on: Teligent, Inc., Healthcare stocks news, Stocks on the move, Read more ...
China Lending (NASDAQ: CLDC ) +35% amid investment, business factoring update. More news on: China Lending Corporation, Teligent, Inc., Xilinx, Inc., Stocks on the move, , Read more ...
BUENA, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA...
BUENA, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA...
NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Caesars Entertainment Corporation (NASDAQ:CZR), Intercept Pharmaceuticals...
BUENA, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies London Healthcare Conference. The Conference is taking place November 14-15, 2018 in London, UK. Jason Grenfell-Gardn...
Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage Canada NewsWire TORONTO, Aug. 14, 2018 TORONTO , Aug. 14, 2018 /CNW/ - Teligent , Inc. (NASDAQ:TLGT) ("Teligent"), a specialty generic pharmaceutical company, averted a natio...
News, Short Squeeze, Breakout and More Instantly...
Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process Company is arranging $12 million debtor-in-possession financing from its senior secured lenders and access to its cash collateral on a consensual basis Canadian entities to pursue sale process outside of Chap...
3 Penny Stocks to Watch With September Halfway Done With September already at the halfway point, there are plenty of penny stocks that investors are watching. And while it may seem easy at first to find valuable penny stocks to buy, it does take some time and a dedication to researc...
BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and provided a business update. “Product demand in our core busin...